Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1.

Tan K, Cho SG, Luo W, Yi T, Wu X, Siwko S, Liu M, Yuan W.

Curr Mol Med. 2014;14(5):652-62.

PMID:
24894166
2.

GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness.

Zajac M, Law J, Cvetkovic DD, Pampillo M, McColl L, Pape C, Di Guglielmo GM, Postovit LM, Babwah AV, Bhattacharya M.

PLoS One. 2011;6(6):e21599. doi: 10.1371/journal.pone.0021599. Epub 2011 Jun 28.

3.

KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.

Cvetkovic D, Dragan M, Leith SJ, Mir ZM, Leong HS, Pampillo M, Lewis JD, Babwah AV, Bhattacharya M.

Endocrinology. 2013 Jun;154(6):1999-2014. doi: 10.1210/en.2012-2164. Epub 2013 Mar 24.

PMID:
23525242
4.

Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition.

Ning Q, Liu C, Hou L, Meng M, Zhang X, Luo M, Shao S, Zuo X, Zhao X.

PLoS One. 2013 Jun 11;8(6):e65217. doi: 10.1371/journal.pone.0065217. Print 2013.

5.

The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review).

Ji K, Ye L, Mason MD, Jiang WG.

Int J Mol Med. 2013 Oct;32(4):747-54. doi: 10.3892/ijmm.2013.1472. Epub 2013 Aug 21. Review.

PMID:
23969598
6.

Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.

Gründker C, Bauerschmitz G, Knapp J, Schmidt E, Olbrich T, Emons G.

Breast Cancer Res Treat. 2015 Jul;152(1):41-50. doi: 10.1007/s10549-015-3463-7. Epub 2015 Jun 11.

PMID:
26062751
7.

Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.

Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB.

J Cell Sci. 2014 Jan 1;127(Pt 1):85-100. doi: 10.1242/jcs.132779. Epub 2013 Nov 8.

8.

Antiproliferative effects of kisspeptin‑10 depend on artificial GPR54 (KISS1R) expression levels.

Ziegler E, Olbrich T, Emons G, Gründker C.

Oncol Rep. 2013 Feb;29(2):549-54. doi: 10.3892/or.2012.2135. Epub 2012 Nov 14.

PMID:
23152107
9.

KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.

Wang CH, Qiao C, Wang RC, Zhou WP.

Mol Med Rep. 2016 Jan;13(1):123-9. doi: 10.3892/mmr.2015.4535. Epub 2015 Nov 9.

10.

Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition.

Song GQ, Zhao Y.

Oncol Rep. 2015 Feb;33(2):669-74. doi: 10.3892/or.2014.3619. Epub 2014 Nov 24.

PMID:
25420482
11.

Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.

Wang XX, Zhu Z, Su D, Lei T, Wu X, Fan Y, Li X, Zhao J, Fu L, Dong JT, Fu L.

Hum Pathol. 2011 Oct;42(10):1410-9. doi: 10.1016/j.humpath.2010.12.007. Epub 2011 Mar 21.

PMID:
21419475
12.

Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.

Cui B, Zhang S, Chen L, Yu J, Widhopf GF 2nd, Fecteau JF, Rassenti LZ, Kipps TJ.

Cancer Res. 2013 Jun 15;73(12):3649-60. doi: 10.1158/0008-5472.CAN-12-3832.

13.

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N.

Endocr Relat Cancer. 2007 Sep;14(3):691-702.

14.

Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.

Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH.

J Pathol. 2012 Oct;228(2):158-69. doi: 10.1002/path.3988. Epub 2012 May 23.

PMID:
22247069
15.

Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail.

Du C, Zhang C, Hassan S, Biswas MH, Balaji KC.

Cancer Res. 2010 Oct 15;70(20):7810-9. doi: 10.1158/0008-5472.CAN-09-4481. Epub 2010 Oct 12. Erratum in: Cancer Res. 2010 Dec 1;70(23):10015.

16.

Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis.

Navenot JM, Fujii N, Peiper SC.

Mol Pharmacol. 2009 Jun;75(6):1300-6. doi: 10.1124/mol.109.055095. Epub 2009 Mar 13.

17.

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T.

PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.

18.

3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.

Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH, Way TD, Chen WJ.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):746-56. doi: 10.1016/j.taap.2013.07.019. Epub 2013 Aug 3.

PMID:
23921149
19.

GPR54 is a target for suppression of metastasis in endometrial cancer.

Kang HS, Baba T, Mandai M, Matsumura N, Hamanishi J, Kharma B, Kondoh E, Yoshioka Y, Oishi S, Fujii N, Murphy SK, Konishi I.

Mol Cancer Ther. 2011 Apr;10(4):580-90. doi: 10.1158/1535-7163.MCT-10-0763. Epub 2011 Jan 31.

20.

Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3 beta-FAK feedback loop in HTR8SVneo cells.

Roseweir AK, Katz AA, Millar RP.

Placenta. 2012 May;33(5):408-15. doi: 10.1016/j.placenta.2012.02.001. Epub 2012 Feb 18.

PMID:
22349353

Supplemental Content

Support Center